Canada markets open in 4 hours 58 minutes

PHC Holdings Corporation (PHCCF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
8.100.00 (0.00%)
At close: 03:45PM EDT

PHC Holdings Corporation

2-38-5 Nishishimbashi
Minato-ku
Tokyo 105-8433
Japan

https://phchd.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees9,403

Key Executives

NameTitlePayExercisedYear Born
Ms. Kyoko DeguchiPresident, CEO & ChairmanN/AN/A1965
Frederick ReidenbachExecutive Corporate Officer & CFON/AN/AN/A
Mr. Koichiro SatoSenior EVP, COO & Representative DirectorN/AN/A1973
Ryuichi HirashimaSr. Exec Corporate Officer, Chief Admin. Officer, Chief HR Officer & Chief Transformation OfficerN/AN/AN/A
Robert SchummCorporate OfficerN/AN/AN/A
Nobuaki NakamuraExecutive Corporate OfficerN/AN/AN/A
Kaiju YamaguchiExecutive Corporate Officer & Chief Strategy OfficerN/AN/AN/A
Steven LynumCorporate OfficerN/AN/AN/A
Hideaki TakahashiCorporate OfficerN/AN/AN/A
Chikara TakauoCorporate OfficerN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

PHC Holdings Corporation, through its subsidiaries, offers medical devices, healthcare IT solutions, and life science products and services primarily in Japan. It operates through Diabetes Management, Healthcare Solutions, and Diagnostic & Life Sciences segments. The company offers blood glucose monitoring systems, continuous glucose monitoring systems, and diabetes application; patient and record billing software, including electronic medical record system, electronic medication history system, and healthcare note service; and diagnostic testing products, which include clinical testing, diagnostic reagents and instruments, and drug development support products. It also provides biologic and cell preservation products, comprising low temperature freezers, CO2 incubators, and automatic tablet counting and packaging system; and cancer pathology products, which comprise tissue processor, microscopic slides, and cytology staining solutions. In addition, the company develops and produces precision medical devices that help with early detection and ongoing monitoring of diseases, such as diabetes and asthma, and drug delivery systems that support medical treatment. The company was formerly known as Panasonic Healthcare Holdings Co., Ltd. and changed its name to PHC Holdings Corporation in April 2018. PHC Holdings Corporation was incorporated in 2013 and is headquartered in Tokyo, Japan.

Corporate Governance

PHC Holdings Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.